TTY BIOPHARM COMPANY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.6 TWD | +0.26% |
|
+0.26% | -4.73% |
| 05-30 | TTY Biopharm Company Limited Announces Change of Members of Audit Committee | CI |
| 05-30 | TTY Biopharm Company Limited Announces Change of Members of Sustainable Development Committee | CI |
ETFs positioned on TTY Biopharm Company Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 114 M€ | +5.07% | - | |
| 0.00% | 32 M€ | +4.26% | - |
TTY Biopharm Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of pharmaceutical preparations. The Company mainly operates through six business segments including Cancer Drug segment, Healthcare segment, Anti-Infective Drug segment, Domestic Cardiovascular and Gastrointestinal Drug segment, Mainland Medical Drug segment and the Other segment. The main products include oncology medicines, anti-infective medicines and health care medicines. Oncology medicines are mainly anti-cancer and auxiliary drugs. Anti-infective medicines are mainly back-line antimicrobial agents and influenza vaccines. Medical and health care medicines are mainly gastrointestinal health care, bone health care, metabolic health care, infection treatment drugs. The Company distributes its products in domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
01/08/2024
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
76.6
TWD
Average target price
78
TWD
Spread / Average Target
+1.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.73% | 588M | |
| +51.63% | 796B | |
| +40.85% | 628B | |
| -5.10% | 358B | |
| +19.90% | 331B | |
| +9.95% | 301B | |
| +17.36% | 244B | |
| +3.76% | 228B | |
| +12.76% | 214B | |
| +6.99% | 165B |
- Stock Market
- Equities
- 4105 Stock
- Funds and ETFs TTY Biopharm Company Limited
